151. Systematic Review of Economic Evaluations of Units Dedicated to Acute Coronary Syndromes.
- Author
-
Azeredo-Da-Silva AL, Perini S, Rigotti Soares PH, and Polaczyk CA
- Subjects
- Acute Coronary Syndrome diagnosis, Acute Coronary Syndrome mortality, Coronary Care Units standards, Cost Savings, Cost-Benefit Analysis, Decision Support Techniques, Humans, Models, Economic, Patient Admission economics, Quality Indicators, Health Care, Quality-Adjusted Life Years, Treatment Outcome, Acute Coronary Syndrome economics, Acute Coronary Syndrome therapy, Coronary Care Units economics, Hospital Costs
- Abstract
Background: Dedicated units for the care of acute coronary syndrome (ACS) have been submitted to economic evaluations; however, the results have not been systematically presented., Objective: To identify and summarize economic outcomes of studies on hospital units dedicated to the initial care of patients with suspected or confirmed ACS., Methods: A systematic review of literature to identify economic evaluations of chest pain unit (CPU), coronary care unit (CCU), or equivalent units was done. Two search strategies were used: the first one to identify economic evaluations irrespective of study design, and the second one to identify randomized clinical trials that reported economic outcomes. The following databases were searched: MEDLINE, EMBASE, CENTRAL, and National Health Service (NHS)Economic Evaluation Database. Data extraction was performed by two independent reviewers. Costs were inflated to 2012 values., Results: Search strategies retrieved five partial economic evaluations based on observational studies, six randomized clinical trials that reported economic outcomes, and five model-based economic evaluations. Overall, cost estimates based on observational studies and randomized clinical trials reported statistically significant cost savings of more than 50% with the adoption of CPU care instead of routine hospitalization or CCU care for suspected low-to-intermediate risk patients with ACS (median per-patient cost US $1,969.89; range US $1,002.12-13,799.15). Model-based economic evaluations reported incremental cost-effectiveness ratios below US $ 50,000/quality-adjusted life-year for all comparisons between intermediate care unit, CPU, or CCU with routine hospital admissions. This finding was sensible to myocardial infarction probability., Conclusions: Published economic evaluations indicate that more intensive care is likely to be cost-effective in comparison to routine hospital admission for patients with suspected ACS., (Copyright © 2016. Published by Elsevier Inc.)
- Published
- 2016
- Full Text
- View/download PDF